Jinyu Bio-Technology Co Ltd
SSE:600201
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jinyu Bio-Technology Co Ltd
Other
Jinyu Bio-Technology Co Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jinyu Bio-Technology Co Ltd
SSE:600201
|
Other
-¥216.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Other
-¥166.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Other
¥75.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Other
-¥107.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Other
-¥138.9m
|
CAGR 3-Years
-138%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Other
-¥2.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jinyu Bio-Technology Co Ltd
Glance View
Jinyu Bio-Technology Co Ltd., a hallmark of scientific innovation and agricultural care, operates at the intersection of biotech and animal health services, focusing primarily on the production of vaccines for livestock. Founded with the vision to enhance animal well-being and agricultural productivity, the company's trajectory has been marked by a commitment to research and development. This dedication is evidenced by its expansive portfolio, which features an array of vaccines aimed at safeguarding livestock against prevalent and virulent diseases. By investing heavily in R&D, Jinyu ensures that its product offerings remain at the frontier of technological advancement and efficacy. The company's modern facilities, equipped with state-of-the-art technology, facilitate the production of high-quality vaccines that adhere to international standards. The company's business model is intricately tied to its strategic positioning within the agricultural ecosystem. By catering to a critical segment—livestock and poultry farmers—Jinyu not only supplies essential vaccines but also provides veterinary services and support, ensuring a holistic approach to animal health. This dual role as a product supplier and service provider enables Jinyu Bio-Technology Co Ltd. to forge long-lasting relationships with its clientele, enhancing customer loyalty and creating a stable revenue stream. Moreover, its efforts in capturing emerging markets, particularly in regions where agricultural development is accelerating, signal a forward-thinking approach that seeks to tap into new growth avenues. Through these strategies, Jinyu continues to reinforce its stature as a pivotal player in the animal health domain, working diligently to marry profitability with sustainable agricultural development.
See Also
What is Jinyu Bio-Technology Co Ltd's Other?
Other
-216.8m
CNY
Based on the financial report for Sep 30, 2025, Jinyu Bio-Technology Co Ltd's Other amounts to -216.8m CNY.
What is Jinyu Bio-Technology Co Ltd's Other growth rate?
Other CAGR 3Y
12%
Over the last year, the Other growth was -2 503%. The average annual Other growth rates for Jinyu Bio-Technology Co Ltd have been 12% over the past three years .